HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heng-Ying Pu Selected Research

Heng-Ying Pu Research Topics

Disease

8Neoplasms (Cancer)
01/2023 - 04/2017
6Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 11/2018
2Stomach Neoplasms (Stomach Cancer)
01/2023 - 01/2019
2Esophageal Squamous Cell Carcinoma
01/2023 - 01/2020
2Carcinogenesis
01/2021 - 01/2019
1Esophageal Neoplasms (Esophageal Cancer)
01/2023
1Acidosis
01/2020
1Hypoxia (Hypoxemia)
06/2019
1Neoplasm Metastasis (Metastasis)
11/2018
1Lung Neoplasms (Lung Cancer)
04/2017

Drug/Important Bio-Agent (IBA)

5Long Noncoding RNAIBA
01/2023 - 12/2019
3Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2020
2Fumarate Hydratase (Fumarase)IBA
01/2023 - 01/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2019
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 01/2020
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
12/2022
1CholesterolIBA
12/2022
1LigandsIBA
12/2022
1cysteine desulfuraseIBA
01/2022
1EnzymesIBA
01/2022
1IronIBA
01/2022
1SulfurIBA
01/2022
1TransposasesIBA
01/2020
1Nuclear Export Signals (Nuclear Export Signal)IBA
01/2020
1Vitamin DFDA LinkGeneric
01/2020
1PPAR deltaIBA
01/2020
1ChromatinIBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Calcitriol Receptors (Calcitriol Receptor)IBA
01/2020
1NADP (NADPH)IBA
06/2019
1Fatty Acids (Saturated Fatty Acids)IBA
11/2018
1MicroRNAs (MicroRNA)IBA
04/2017

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2023 - 01/2019
1Immunotherapy
01/2023